Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
Study of Mesenchymal Autologous Stem Cells as Regenerative Treatment for Multiple SclerosisCNS demyelinating autoimmune disease, Chronic Disease, Disease Attributes, Pathologic Processes, Pathological Conditions, Signs and Symptoms, autoimmune disease, autoimmune disorder of the nervous system, chronic progressive multiple sclerosis, demyelinating disease, immune system disorder, multiple sclerosis, nervous system disorderActive, not recruitingPhase 1 / Phase 22026-03-12NCT04749667

6 results · Page 1 of 1

4 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sitesCityCountryLinked trials
Akershus university hospitalLørenskogNorway2
Haukeland University HospitalBergenNorway2
St.Olav university hospitalTrondheimNorway1
University hospital of North NorwayTromsøNorway1